Surprisingly, chalcone, with chemical modification by dithiocarbamate scaffolds, suppressed the cell growth, migration and invasion of ESCC cells targeting PRR11 [30], showing great potential application for targeted therapy of ESCC patients. Here, PRR11 is linked to esophageal squamous cell carcinoma.